Development of specific scFv antibodies to detect neurocysticercosis antigens and potential applications in immunodiagnosis

Immunology Letters

Volumn 156, Issue 1-2, 2013, Pages 59-67

  Ribeiro, Vanessa da Silva ^a   Araújo, Thaise Gonçalves ^a   Gonzaga, Henrique Tomaz ^a   Nascimento, Rafael ^a   Goulart, Luiz Ricardo ^a   Costa Cruz, Julia Maria ^a  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

Author keywords

ELISA; Immunofluorescence; Phage displayed peptides; ScFv; Taenia solium

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ANTIBODY DETECTION; ANTIBODY ISOLATION; ANTIGEN BINDING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE TEST; MASS SPECTROMETRY; METACESTODE; NEUROCYSTICERCOSIS; NUCLEOTIDE SEQUENCE; PHAGE DISPLAY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; TAENIA SOLIUM;

ELISA; IMMUNOFLUORESCENCE; PHAGE DISPLAYED PEPTIDES; SCFV; TAENIA SOLIUM;

ANIMALS; ANTIBODIES, HELMINTH; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ANTIGENS, HELMINTH; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HOST-PARASITE INTERACTIONS; HUMANS; MASS SPECTROMETRY; NEUROCYSTICERCOSIS; PEPTIDE LIBRARY; SENSITIVITY AND SPECIFICITY; SINGLE-CHAIN ANTIBODIES; TAENIA SOLIUM;

EID: 84885811550     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2013.09.005     Document Type: Article

References (39)

1. Martinez-Ocaña J., Romero-Valdovinos M., Kaminsky R.G., Maravilla P., Flisser A. Immunolocalization of TSOL18 and TSOL45-1A, the successful protective peptides against porcine cysticercosis, in Taenia solium oncospheres. Parasites Vectors 2011, 4:1-3.
2. Praet N., Speybroeck N., Rodriguez-Hidalgo R., Benitez-Ortiz W., Berkvens D., Brandt J., et al. Age-related infection and transmission patterns of human cysticercosis. Int J Parasitol 2010, 40:85-90.
3. Hoogenboom H.R. Selecting and screening recombinant antibody libraries. Nat Biotechnol 2005, 23:1105-1116.
4. Thie H., MeyerT.Schirrmann T., Hust M., Dübel S. Phage display derived therapeutic antibodies. Curr Pharm Biotechnol 2008, 9:439-446.
5. Dübel S., Stoevesandt O., Taussig M.J., Hust M. Generating recombinant antibodies to the complete human proteome. Trends Biotechnol 2010, 28:333-339.
6. Arap M.A. Phage display technology-applications and innovations. Genet Mol Biol 2005, 28:1-9.
7. Neria P., Shigemori N., Hamada-Tsutsumi S., Tsukamotoa K., Arimitsu H., Shimizu T., et al. Single chain variable fragment antibodies against Shiga toxins isolated from a human antibody phage display library. Vaccine 2011, 29:5340-5346.
8. Ahmad Z.Z., Yeap S.K., Ali A.M., Ho W.Y., Alitheen N.B.M., Hamid M. ScFv antibody: principles and clinical application. Clin Dev Immunol 2012, 2012. Article ID 980250.
9. Griffiths A.D., Duncan A.R. Strategies for selection of antibodies by phage display. Curr Opin Biotechnol 1998, 9(1):102-108.
10. Lun Y.Z., Cheng J., Zhong Y.W., Yu Z.G., Wang Q., Wang F., et al. Cloning, expression and identification by immunohistochemistry of humanized single-chain variable fragment antibody against hepatitis C virus core protein. Pol J Microbiol 2011, 60:13-17.
11. Costa J.M., Ferreira A.W., Makino M.M., Camargo M.E. Spinal fluid immunoenzymatic assay (ELISA) for neurocysticercosis. Rev Inst Med Trop São Paulo 1982, 24:337-341.
12. Ribeiro V.S., Manhani M.N., Cardoso R., Vieira C.U., Goulart L.R., Costa-Cruz J.M. Selection of high affinity peptide ligands for detection of circulating antibodies in neurocysticercosis. Immunol Lett 2010, 129:94-99.
13. Barbas C.F., Burton D.R., Scott J.K., Silvermam G.J. Phage display. A laboratory manual 2000, Cold Spring Harbor Laboratory Press, New York.
14. Friedman R.D. Comparation of four different silver-staining techniques for salivary protein detection in alkaline polyacrylamide gels. Ann Biochem 1982, 126:346-349.
15. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976, 72:248-254.
16. Baerman G. Eine einfache Methode zur Auffindung von Ankylostomum (Nematoden) Larven in Erdproben. In Mededelingen uit het Geneeskundig Laboratorium te Weltevreden. H. Geneesk, Batavia 1917.
17. Lutz A. O Schistosomum mansoni e a schistosomatose segundo observações feitas no Brasil. Mem Inst Oswaldo Cruz 1919, 11:121-155.
18. Gonzaga H.T., Ribeiro V.S., Cunha-Júnior J.P., Ueta M.T., Costa-Cruz J.M. Usefulness of concanavalin-A non-binding fraction of Strongyloides venezuelensis larvae to detect IgG and IgA in human strongyloidiasis. Diagn Microbiol Infect Dis 2011, 70:78-84.
19. Greiner M., Sohr D., Göbel P. A modified ROC analysis for the selection of cut-off values and the definition of intermediate results of serodiagnostic tests. J Immunol Methods 1995, 185:123-132.
20. Youden W.J. Index for rating diagnostic tests. Cancer 1950, 3:32-35.
21. Martinez E.Z., Louzada-Neto F., Pereira B.B. A curva ROC para testes diagnósticos. Cad Saúde Coletiva 2003, 11:7-31.
22. Hanley J.A., Macneil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982, 143:29-36.
23. Griffiths A.D., Williams S.C., Hartley O., Tomlinson I.M., Waterhouse P., Crosby W.L., et al. Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J 1994, 13:3245-3260.
24. Vaughan T.J., Williams A.J., Pritchard K., Osbourn J.K., Pope A.R., Earnshaw J.C., et al. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nat Biotechnol 1996, 14:309-314.
25. Sheets M.D., Amersdorfer P., Finnern R., Sargent P., Lindqvist E., Schier R., et al. Efficient construction of a large nonimmune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens. Proc Natl Acad Sci USA 1998, 95:6157-6162.
26. Sepulveda J., Tremblay J.M., DeGnore J.P., Skelly P.J., Shoemaker C.B. Schistosoma mansoni host-exposed surface antigens characterized by sera and recombinant antibodies from schistosomiasis-resistant rats. Int J Parasitol 2010, 40:1407-1417.
27. Shanmugam A., Suriano R., Goswami N., Chaudhuri D., Ashok B.T., Rajoria S., et al. Identification of peptide mimotopes of gp96 using single-chain antibody library. Cell Stress Chaperones 2011, 16:225-234.
28. Willms K., Vargas-Parada L., Laclette P.J. Biologia del parasito. Cisticercosis: guía para profesionales de lasalud, Biblioteca de la Salud, Secretaría de Salud, Fundación Mexicana para laSalud 2006, Instituto Nacional de Salud Pública y Fondo de Cultura Económica, México D.F. S.A. Aluja, R. Carrillo-Mezo, A. Chavarría, A. Escobar, A. Flisser, A. Fleury, G. Fragoso, C. Larralde, E. Sciutto, J. Sotelo, K. Willms, L. Vargas-Parada, P.J. Laclette (Eds.).
29. Jaeschke R., Guyatt G.H., Sacket D.L. Users' guide to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. J Am Med Assoc 1994, 271:703-707.
30. Suzuki L.A., Rossi C.L. Evaluation of two Taenia solium cysticercal antigenic preparations (vesicular fluid and a glycoprotein fraction with affinity for lentil lectin) for the immunodiagnosis of neurocysticercosis by enzyme-linked immunosorbent assay (ELISA). Arq Neuropsiquiatr 2011, 69(3):470-474.
31. Lee E.G., Bae Y.A., Kim S.H., Díaz-Camacho S.P., Nawa Y., Kong Y. Serodiagnostic reliability of single-step enriched low-molecular weight proteins of Taenia solium metacestode of American and Asian isolates. Trans R Soc Trop Med Hyg 2010, 104:676-683.
32. Machado G.A., Santiago F.M., Mineo J.R., Costa-Cruz J.M. Assessment of antigenic fractions of varying hydrophobicity from Taenia solium metacestodes for the diagnosis of human neurocysticercosis. Trop Med Int Health 2007, 12:1369-1376.
33. Handali S., Klarman M., Gaspard A.N., Noh J., Lee Y.M., Rodriguez S., et al. A multi-antigen print immunoassay (MAPIA) for comparison of diagnostic antigens for Taenia solium cysticercosis and taeniasis. Clin Vacc Immunol 2009, 17:68-72.
34. Lee Y.M., Handali S., Hancock K., Pattabhi S., Kovalenko V.A., Levin A., et al. Serologic diagnosis of human Taenia solium cysticercosis by using recombinant and synthetic antigens in QuickELISA™. Am J Trop Med Hyg 2011, 84:587-593.
35. Carod J.F., Randrianarison M., Razafimahefa J., Ramahefarisoa R.M., Rakotondrazaka M. Evaluation of the performance of 5 commercialized enzyme immunoassays for the detection of Taenia solium antibodies and for the diagnosis of neurocysticercosis. Diagn Microbiol Infect Dis 2012, 72:85-89.
36. Pardini A.X., Vaz A.J., Machado L.R., Livramento J.A. Cysticercus antigens in cerebrospinal fluid samples from patients with neurocysticercosis. J Clin Microbiol 2001, 39:3368-3372.
37. Garcia H.H., Gonzalez A.E., Gilman R.H., Bernal T., Rodriguez S., Pretell E.J., et al. Circulating parasite antigen in patients with hydrocephalus secondary to neurocysticercosis. Am J Trop Med Hyg 2002, 66:427-430.
38. Garcia H.H., Dorny P., Castillo Y., Pretell E.J., Rodriguez S., Mija L., et al. Circulating antigen levels follow post-treatment evolution of subarachnoid neurocysticercosis. J Neuroparasitol 2010, 1:1-3.
39. Fleury A., Garcia E., Hernandez M., Carrillo R., Govezensky T., Fragoso G., et al. HP10 antigen detection is useful for the follow-up of the severe patients. PLoS Neglect Trop Dis 2013, 7:e2096.